AURORA, Colorado, Sept. 12 [Category: Medical] -- The International Association for the Study of Lung Cancer posted the following news release:

* * *

Local Consolidative Therapy Does Not Improve Survival After Dual Immunotherapy in Metastatic NSCLC

*

(SEOUL, Republic of Korea -Saturday, September 12th, 6:15 p.m. Korea Standard Time) - Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not impro . . .

Click here for more information about our products